+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-01-12Number of Pages: 82

Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

The Centers for Disease Control and Prevention (CDC) reported that there were 44 million adults addicted to smoking in 2011 in the U.S. The majority of these addicts belonged to the low-income groups in the country. On a similar note, the World Health Organization stated that Europe has the biggest pool of smokers, while Asia Pacific has a high percentage of cigarette smokers in comparison to North America and Europe. These dismaying facts and figures are only expected to rise in the near future, which will snowball into a range of medical conditions, some life-changing while some that will meet the fatal end.

This grim reality has forced governments across the globe, non-profit organizations, and the vast pharmaceutical industry to take strict measures to help nicotine addicts. These reasons have collectively triggered a huge demand for smoking cessation aids that mainly include nicotine replacement therapy (NRT) products. Transparency Market Research reports that the opportunities in the global smoking cessation and nicotine de-addiction products market will be worth US$20.5 bn by 2023 from US$6.5 bn in 2014, as the market progresses at a robust CAGR of 13.7% between 2015 and 2023.

Rising Number of Smokers in the U.S. Make North America Leading Market for Smoking Cessation and Nicotine De-addiction Products

The majority of the countries across the globe are enforcing smoking cessation measures, with North America leading the way. North America was the key regional contributor to the overall market. Its revenue in the market was valued at US$3.25 bn in 2015 and is expected to reach US$8.59 bn by 2023, as it expands at a CAGR of 12.9% between 2015 and 2023.

The increasing number of smokers is expected to fuel smoking cessation and nicotine de-addiction products market in North America. Out of all the products, e-cigarettes will do well in the region as they offer convenient usage in no-smoking areas. Furthermore, their cost-effectiveness and their increasing acceptance over conventional tobacco cigarettes will also boost their demand in the near future.

E-cigarettes Outpace Other Products due to their Convenience

Out of the variety of smoking cessation aids and nicotine de-addiction products available in the market, e-cigarettes are being popularly used. This product segment will witness a strong rise in the global market at robust CAGR of 20.5% between 2015 and 2023. This product operates on a battery to provide the user minimum amount of nicotine through heating and vaporizing. The increasing sales of this specific product are attributable its unique ability to provide the same feeling as smoking a cigarette at a minimal risk to user’s health and wealth.

The next emerging product segment in the global smoking cessation and nicotine de-addiction products market is Champix, which is also known as Chantix. This is a prescription drug that helps the smokers to curb their urge to smoke. This product segment is expected to expand at a CAGR of 14.8% between 2015 and 2023.

Some of the leading players dictating the vendor landscape of the global smoking cessation and nicotine de-addiction products market are NJOY, Johnson & Johnson, GSK, Pfizer, VMR Products LLC, Nicotek LLC., and Lorillard, Inc. These players are making significant investments in conducting clinical trials to assess the safety and efficacy to the products. Furthermore, companies are also strengthening their distribution channels to widen the geographical reach of their products. 

 

1. Preface

2. Executive Summary
     2.1. Introduction 
     2.2. Global Smoking Cessation and Nicotine De-addiction Products Market: Market Snapshot
     2.3. Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography and Analysis

3. Industry Analysis: Smoking Cessation and Nicotine De-addiction Products Market
     3.1. Introduction and Market Definition
     3.2. Market Dynamics
            3.2.1. Drivers
                     3.2.1.1. Rising awareness about smoking health hazards and smoking cessation therapy
                     3.2.1.2. Introduction of new products
                     3.2.1.3. Reimbursement for smoking cessation therapy
            3.2.2. Restraints
                     3.2.2.1. Low awareness about smoking cessation products in developing economies
                     3.2.2.2. Legal obligations dragging growth of several smoking cessation product segments
            3.2.3. Opportunity
                     3.2.3.1. Research and development
                     3.2.3.2. Market expansion in developing economies
     3.3. Market Attractiveness Analysis of Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography
     3.4. Competitive Landscape: Heat Map Analysis

4. Smoking Cessation and Nicotine De-addiction Products Market Segmentation – by Type
     4.1. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013–2023 (US$ Mn)
     4.2. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Nicotine Replacement Therapies, 2013–2023 (US$ Mn)
            4.2.1. Global Nicotine Gums Market Revenue, 2013–2023, (US$ Mn) and Analysis
            4.2.2. Global Nicotine Patches Market Revenue, 2013–2023, (US$ Mn) and Analysis
            4.2.3. Global Nicotine Sprays Market Revenue, 2013–2023, (US$ Mn) and Analysis
            4.2.4. Global Nicotine Inhalers Market Revenue, 2013–2023, (US$ Mn) and Analysis
            4.2.5. Global Nicotine Lozenges Market Revenue, 2013–2023, (US$ Mn) and Analysis
            4.2.6. Global Nicotine Sub lingual Tablets Market Revenue, 2013–2023, (US$ Mn) and Analysis
     4.3. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Drug Therapy, 2013–2023 (US$ Mn)
            4.3.1. Global Bupropione (Zyban) Market Revenue, 2013–2023, (US$ Mn) and Analysis
            4.3.2. Global Varenicline (Champix, Chantix) Market Revenue, 2013–2023, (US$ Mn)
     4.4. Global E- Cigarettes Market Revenue, 2013–2023, (US$ Mn)

5. Smoking Cessation and Nicotine De-addiction Products Market Segmentation – by Geography
     5.1. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Geography, 2013–2023 (US$ Mn)
     5.2. North America
            5.2.1. North America Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013–2023 (US$ Mn) and Analysis
            5.2.2. North America Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013–2023 (US$ Mn) and Analysis
     5.3. Europe
            5.3.1. Europe Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013–2023 (US$ Mn) and Analysis
            5.3.2. Europe Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013–2023 (US$ Mn) and Analysis
     5.4. Asia Pacific
            5.4.1. Asia Pacific Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013–2023 (US$ Mn) and Analysis
            5.4.2. Asia Pacific Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013–2023 (US$ Mn) and Analysis
     5.5. Rest of the World
            5.5.1. Rest of the World Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013–2023 (US$ Mn) and Analysis
            5.5.2. Rest of the World Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013–2023 (US$ Mn) and Analysis

6. Company Profiles
     6.1. Cipla Ltd.
     6.2. GlaxoSmithKline plc
     6.3. Imperial Tobacco Company of India Limited.
     6.4. McNeil AB
     6.5. NJOY, Inc.
     6.6. Novartis International AG
     6.7. Pfizer, Inc.
     6.8. Revolymer PLC
     6.9. Takeda Pharmaceutical Co., Ltd.

Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban (bupropion), and Chantix/Champix (varenicline). Quitting smoking is also possible with or without assistance of healthcare professionals. The smoking cessation products market has been extensively analyzed on the basis of factors such as the products popularly used, success rate, and geographical reach.

The global smoking cessation and nicotine de-addiction market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global smoking cessation and nicotine de-addiction market with respect to the segments based on the type of products, and their geographic analysis (by country). A detailed qualitative analysis of driving and restraining factors for the market growth and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global smoking cessation and nicotine de-addiction market.  

Based on type of products, the smoking cessation and nicotine de-addiction market includes nicotine replacement therapy (NRT) products, drug therapy and e-cigarettes. The NRT products market is broadly segmented into nicotine containing gums, transdermal patches, lozenges, sublingual tablets, sprays and nasal inhalers. The prominently used brands for smoking cessation are Zyban and Chantix/Champix which comprise the drug therapy segment of the market. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW) The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of USD million for each segment has been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.

A competitive landscape, mapping all the market players and their respective shares in the smoking cessation and nicotine de-addiction products market for 2012 are provided in this report. Some of the major players profiled for NRT products include Johnson & Johnson, GSK, Pfizer, Takeda Pharmaceuticals Co. Ltd., Cipla, and Revolymer PLC. GSK and Pfizer lead the market for drug therapy while the key players profiled for e-cigarettes market include VMR products, and NJOY. Each of these smoking cessation and nicotine de-addiction products market players are profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.

The global smoking cessation and nicotine de-addiction products market has been segmented as follows:

Global Smoking Cessation and Nicotine De-Addiction Products Market, by Type

  • Nicotine Replacement Therapy Products
    • Nicotine Gums
    • Nicotine Transdermal Patches
    • Nicotine Lozenges
    • Nicotine Sprays
    • Nicotine Inhalers
    • Nicotine Subling ual Tablets
  • Drug Therapy
    • Zyban (bupropion)
    • Chantix/Champix (varenicline)
  • E-cigarettes

Global Smoking Cessation and Nicotine De-Addiction Products Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Latin America (LATAM)
    • Middle East and North Africa (MENA)